Adrenaline (A) is known to cause significant appetite suppression.
This effect may involve adrenergic receptors located on liver cells (hepatocytes).
Purpose of the Study:
To investigate whether alpha- and/or beta-adrenergic mechanisms mediate the anorexic effects of adrenaline.
To compare the anorexigenic potencies of adrenaline, noradrenaline (NA), and isoproterenol (I) under various feeding and light/dark cycle conditions.
Main Methods:
Intraperitoneal injections of adrenaline, noradrenaline, and isoproterenol were administered to rats.
Experiments were conducted under four conditions: ad libitum feeding during the dark period, a 24h-feeding/24h-fasting schedule during dark and light periods, and after a 24h fast.
The anorexigenic effects were quantified by measuring food intake.
Main Results:
All three catecholamines reduced food intake, with adrenaline showing a slightly stronger effect.
The anorexic effects were more pronounced during the dark period compared to the light period.
Relative potencies varied: Adrenaline > Isoproterenol > Noradrenaline in the dark (II), and Adrenaline > Isoproterenol = Noradrenaline in the light (III) and after fasting (IV).
Alpha and beta adrenergic effects appeared additive, but adrenaline was more potent than a combination of noradrenaline and isoproterenol, suggesting a distinct mechanism.
Conclusions:
Adrenaline's potent anorexic effect is mediated by hepatic adrenergic receptors.
While alpha and beta mechanisms contribute, adrenaline likely acts through a distinct, non-alpha/beta adrenergic pathway on these receptors.
Feeding schedules and light/dark cycles influence catecholamine-induced appetite suppression.